Fred R. Tejada, Ph.D.
Associate Professor, Pharmaceutical Sciences
Dr. Tejada joins the faculty as an Associate Professor in the Department of Pharmaceutical Sciences.
Dr. Tejada graduated with a Ph.D. degree in Chemistry from the University of Texas at Dallas. His graduate research involved the design, synthesis and relaxometric studies of macrocyclic chelates as contrast agents for MRI applications. He was also involved in crystal engineering studies of tolane-containing organic crystals for electronic material applications. For his industrial practicum, he worked as an organic/process chemist at Merck & Co., Inc. in New Jersey. His research at Merck involved beta-lactam chemistry in both the bench and pilot-plant scale.
His post-doctoral research at the University of Toledo College of Pharmacy focused on the synthesis and SAR studies of muscarinic agonists for the possible treatment of neurological disorders, such as schizophrenia and Alzheimer’s disease. He was involved in the various aspects of drug development such as computational, pharmacology and behavioral studies. As a post-doctoral fellow, he helped mentor several undergraduate and graduate students.
In 2007, Dr. Tejada joined the faculty at Appalachian College of Pharmacy in Virginia. At ACP, he taught Medicinal Chemistry, facilitated EPPE forums and served as course coordinator and instructor in the Metabolic Biochemistry module. Dr Tejada has served in several committees including: Curriculum and Assessment, Academic Remediation, Scholarship and Awards, and self-study (ACPE and SACS) committees. While at ACP, Dr Tejada has participated in several community activities including the Remote Area Medical (RAM), diabetes awareness, Great American Smokeout and he was also involved in two health and wellness projects on smoking cessation.
Dr. Tejada is a member of the American Chemical Society- Medicinal Chemistry and American Association of Colleges of Pharmacy. He has published several articles in refereed journals and annually attends national scientific meetings.
